早发性脊柱侧凸生长棒治疗后的最终融合:真的是最终的吗?
该多中心回顾性分析纳入119例早发性脊柱侧凸患者中符合标准的100例(84%),评估生长棒治疗后最终融合后的再手术情况。最终融合后平均随访4.3年,20%的患者因30项并发症接受了再手术,结论认为再手术比例高于预期,需长期随访并向患者及家长告知进一步手术的可能性。
要点
- 最终融合后20%的患者因并发症需再手术,平均每例1.5项并发症。
- 再手术原因包括感染9%、内固定失败6%、疼痛或突出内固定5%等。
- 神经肌肉型8例、综合征型8例、特发性4例需再手术,先天性无再手术。
核心结论
- 接受生长棒治疗的患者在最终融合后非计划再手术的比例高于预期。
- 最终融合后需要长期随访以确定真正的最终结果。
- 需向患者及家长告知最终融合后可能需进一步手术。
研究设计与样本
- 多中心数据库回顾性分析,纳入生长棒治疗后最终融合且随访至少2年的早发性脊柱侧凸患者。
- 119例中100例(84%)符合纳入标准,最终融合时平均年龄12.2岁(范围8.5至18.7岁),最终融合后平均随访4.3年(范围2至11.2年)。
- 病因分布:神经肌肉型38例、综合征型31例、特发性22例、先天性9例。
主要发现
- 20%(20例)患者发生30项需再手术的并发症,共57次手术,平均每例1.5项并发症。
- 再手术患者中神经肌肉型8例、综合征型8例、特发性4例、先天性0例。
- 9%(9例)发生感染(33次再手术),6%(6例)内固定失败(8次手术),5%(5例)疼痛或突出内固定(6次手术)。
- 3%(3例)冠状面畸形(3次手术)、3%(3例)假关节(3次手术)、3%(3例)矢状面畸形(3次手术),1%(1例)进行性曲轴胸壁畸形需胸廓成形术(1次手术)。
局限性
- 证据等级为治疗性IV级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Final fusion is thought to be the end point for patients with early onset scoliosis following treatment with the use of growing rods. But is it? The purpose of this study was to determine the incidence and cause of any reoperation after final fusion. METHODS: A multicenter database of patients with early onset scoliosis was retrospectively analyzed to identify patients treated with growing rods with a minimum of 2 years of follow-up after final fusion. All reoperations were recorded. Reoperation was defined as a return to the operating room for any complication related to the final fusion surgery or etiology of the spinal deformity. RESULTS: One hundred (84%) of 119 patients met the inclusion criteria: for 38 of the patients, the etiology of scoliosis was neuromuscular; for 31, syndromic; for 22, idiopathic; and for 9, congenital. The mean age at final fusion was 12.2 years (range, 8.5 to 18.7 years). The mean follow-up after final fusion was 4.3 years (range, 2 to 11.2 years). Twenty (20%) of the patients had 30 complications requiring reoperation (57 procedures). There was a mean of 1.5 complications per patient after final fusion. Eight patients with neuromuscular scoliosis, 8 with syndromic, 4 with idiopathic, and no patient with congenital scoliosis required reoperation. Nine (9%) of the patients experienced infection (33 reoperation procedures); 6 (6%) had instrumentation failure (8 procedures); 5 (5%) had painful or prominent instrumentation (6 procedures); 3 (3%) each had coronal deformity (3 procedures), pseudarthrosis (3 procedures), or sagittal deformity (3 procedures); and 1 (1%) had progressive crankshaft chest wall deformity requiring a thoracoplasty (1 procedure). CONCLUSIONS: A higher-than-anticipated percentage of patients treated with growing rods required unplanned reoperation following final fusion. Long-term follow-up after final fusion is necessary to determine true final results. Patients and parents need to be counseled regarding the possibility of further surgery after final fusion. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Poe-Kochert C, Shannon C, Pawelek JB, et al. Final Fusion After Growing-Rod Treatment for Early Onset Scoliosis: Is It Really Final? J Bone Joint Surg Am. 2016. PMID: 27852908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。